Variation in physician recommendations, knowledge and perceived roles regarding provision of end-of-life care

BMC Palliative Care

Volumn 14, Issue 1, 2015, Pages

  Malhotra, Chetna ^a   Chan, Noreen ^b   Zhou, Jamie ^b   Dalager, Hannah B ^c   Finkelstein, Eric ^a  

^a DUKE NUS MEDICAL SCHOOL   (Singapore)

^b Cancer Institute   (Singapore)

^c SYRACUSE UNIVERSITY   (United States)

Author keywords

Best worst scaling; Pain management; Palliative care; Perceived roles; Terminal care; Treatment recommendations; Vignettes

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ANALGESIA; ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; CRITICAL ILLNESS; CROSS-SECTIONAL STUDY; DISEASE SEVERITY; FEMALE; HEALTH CARE COST; HUMAN; LIFE EXTENSION; MALE; MEDICAL DECISION MAKING; MEDICAL EDUCATION; PALLIATIVE THERAPY; PATIENT REFERRAL; PHYSICIAN ATTITUDE; PROFESSIONAL KNOWLEDGE; PROGNOSIS; SEX DIFFERENCE; SURVIVAL RATE; SURVIVAL TIME; TERMINAL CARE; WORK EXPERIENCE; ATTITUDE TO HEALTH; DOCTOR PATIENT RELATION; MIDDLE AGED; PERCEPTION; PROCEDURES; PSYCHOLOGY; QUESTIONNAIRE; SINGAPORE;

ADULT; AGED; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MALE; MIDDLE AGED; PERCEPTION; PHYSICIAN'S ROLE; PHYSICIAN-PATIENT RELATIONS; SINGAPORE; SURVEYS AND QUESTIONNAIRES; TERMINAL CARE;

EID: 84959150870     PISSN: None     EISSN: 1472684X     Source Type: Journal    
DOI: 10.1186/s12904-015-0050-y     Document Type: Article

References (31)

1. Mercuri M, Gafni A. Medical practice variations: what the literature tells us (or does not) about what are warranted and unwarranted variations. J Eval Clin Pract. 2011;17(4):671-7. doi: 10.1111/j.1365-2753.2011.01689.x.
2. Davis P, Gribben B, Lay-Yee R, Scott A. How much variation in clinical activity is there between general practitioners? A multi-level analysis of decision-making in primary care. J Health Serv Res Policy. 2002;7(4):202-8. doi: 10.1258/135581902320432723.
3. Vincent JL. Forgoing life support in western European intensive care units: the results of an ethical questionnaire. Crit Care Med. 1999;27(8):1626-33.
4. Fainsinger R, Waller A, Bercovici M, Bengtson K, Landman W, Hosking M, et al. A multicentre international study of sedation for uncontrolled symptoms in terminally ill patients. Palliat Med. 2000;14(4):257-65.
5. Ball CG, Navsaria P, Kirkpatrick AW, Vercler C, Dixon E, Zink J, et al. The impact of country and culture on end-of-life care for injured patients: results from an international survey. J Trauma Acute Care Surg. 2010;69(6):1323-34.
6. Raijmakers N, van Zuylen L, Furst C, Beccaro M, Maiorana L, Pilastri P, et al. Variation in medication use in cancer patients at the end of life: a cross-sectional analysis. Support Care Cancer. 2013;21(4):1003-11.
7. Low JA, Ng WC, Yap KB, Chan KM. End-of-life issues - preferences and choices of a group of elderly Chinese subjects attending a day care centre in Singapore. Ann Acad Med Singap. 2000;29(1):50-6.
8. Lim MK. Shifting the burden of health care finance: a case study of public-private partnership in Singapore. Health Policy. 2004;69(1):83-92.
9. Phua J, Kee AC, Tan A, Mukhopadhyay A, See KC, Aung NW, et al. End-of-life care in the general wards of a Singaporean hospital: an Asian perspective. J Palliat Med. 2011;14(12):1296-301. doi: 10.1089/jpm.2011.0215.
10. Lien Centre for Palliative Care. Report of a National Education Needs Assessment of Healthcare Professionals for Palliative Care in Singapore 2014.
11. Smith TJ, Temin S, Alesi ER, Abernethy AP, Balboni TA, Basch EM, et al. American Society of Clinical Oncology provisional clinical opinion: the integration of palliative care into standard oncology care. J Clin Oncol. 2012;30(8):880-7. doi: 10.1200/JCO.2011.38.5161.
12. Peabody JW, Luck J, Glassman P, Jain S, Hansen J, Spell M, et al. Measuring the quality of physician practice by using clinical vignettes: a prospective validation study. Ann Intern Med. 2004;141(10):771-80.
13. Peabody JW, Luck J, Glassman P, Dresselhaus TR, Lee M. Comparison of vignettes, standardized patients, and chart abstraction: a prospective validation study of 3 methods for measuring quality. JAMA. 2000;283(13):1715-22.
14. Sawtooth Software. Sawtooth Software. http://www.sawtoothsoftware.com/. Accessed May 6 2015.
15. Louviere JJ, Hensher DA, Swait JD. Stated choice methods: analysis and applications. Cambridge University Press; Cambridge, United Kingdom. 2000.
16. Flynn TN. Valuing citizen and patient preferences in health: recent developments in three types of best-worst scaling. Expert Rev Pharmacoecon Outcomes Res. 2010;10(3):259-67. doi: 10.1586/erp.10.29.
17. Louviere JJ, Flynn TN. Using best-worst scaling choice experiments to measure public perceptions and preferences for healthcare reform in australia. Patient. 2010;3(4):275-83. doi: 10.2165/11539660-000000000-00000.
18. Coxe S, West SG, Aiken LS. The analysis of count data: A gentle introduction to Poisson regression and its alternatives. J Pers Assess. 2009;91(2):121-36.
19. Gallego G, Bridges JF, Flynn T, Blauvelt BM, Niessen LW. Using best-worst scaling in horizon scanning for hepatocellular carcinoma technologies. Int J Technol Assess Health Care. 2012;28(3):339-46. doi: 10.1017/S026646231200027X.
20. Gorin SS, Heck JE, Albert S, Hershman D. Treatment for breast cancer in patients with Alzheimer's disease. J Am Geriatr Soc. 2005;53(11):1897-904. doi: 10.1111/j.1532-5415.2005.00467.x.
21. Raji MA, Kuo YF, Freeman JL, Goodwin JS. Effect of a dementia diagnosis on survival of older patients after a diagnosis of breast, colon, or prostate cancer: implications for cancer care. Arch Intern Med. 2008;168(18):2033-40. doi: 10.1001/archinte.168.18.2033.
22. Gupta SK, Lamont EB. Patterns of presentation, diagnosis, and treatment in older patients with colon cancer and comorbid dementia. J Am Geriatr Soc. 2004;52(10):1681-7. doi: 10.1111/j.1532-5415.2004.52461.x.
23. Robb C, Boulware D, Overcash J, Extermann M. Patterns of care and survival in cancer patients with cognitive impairment. Crit Rev Oncol Hematol. 2010;74(3):218-24. doi: 10.1016/j.critrevonc.2009.07.002.
24. Bakogeorgos M, Mountzios G, Kotsantis G, Economopoulou P, Fytrakis N, Kentepozidis N. Chemotherapy compliance, tolerance and efficacy in elderly and non-elderly patients with metastatic colorectal cancer: a single institution comparative study. J BUON. 2013;18(3):629-34.
25. Jehn CF, Böning L, Kröning H, Pezzutto A, Lüftner D. Influence of comorbidity, age and performance status on treatment efficacy and safety of cetuximab plus irinotecan in irinotecan-refractory elderly patients with metastatic colorectal cancer. European Journal of Cancer.50(7):1269-75. doi: 10.1016/j.ejca.2014.01.005.
26. Evans JG. Aging and rationing. BMJ. 1991;303(6807):869-70.
27. Newcomb PA, Carbone PP. Cancer treatment and age: patient perspectives. J Natl Cancer Inst. 1993;85(19):1580-4.
28. Hamel MB, Teno JM, Goldman L, Lynn J, Davis RB, Galanos AN, et al. Patient age and decisions to withhold life-sustaining treatments from seriously ill, hospitalized adults. SUPPORT Investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatment. Ann Intern Med. 1999;130(2):116-25.
29. Hubbard RE, O'Mahony MS, Woodhouse KW. Medication prescribing in frail older people. Eur J Clin Pharmacol. 2013;69(3):319-26. doi: 10.1007/s00228-012-1387-2.
30. Dickinson GE. A quarter century of end-of-life issues in U.S. medical schools. Death Stud. 2002;26(8):635-46. doi: 10.1080/07481180290088347.
31. Case AA, Orrange SM, Weissman DE. Palliative medicine physician education in the United States: a historical review. J Palliat Med. 2013;16(3):230-6. doi: 10.1089/jpm.2012.0436.